Brief: Aroa Biosurgery Posts H1 Product Revenue NZ$39.1 Million
Nov 26 (Reuters) - Aroa Biosurgery H1 product revenue NZD 39.1 million. * H1 adjusted operating expenses NZD 33.2 million * H1 product gross margin 87% * H1 adjusted EBITDA NZD -1.5 million * H1 adjusted pretax profit NZD -3.515 million * H1 gross profit NZD 33.981 million * H1 adjusted EBIT NZD -3.953 million